Myriad Genetics, Inc. (MYGN)
4.42
+0.04
(+0.91%)
USD |
NASDAQ |
Feb 24, 15:09
Myriad Genetics Total Assets (Quarterly) : 728.10M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ICU Medical, Inc. | 4.051B |
| Intuitive Surgical, Inc. | 20.63B |
| Insulet Corp. | 3.190B |
| West Pharmaceutical Services, Inc. | 4.27B |
| Celldex Therapeutics, Inc. | 648.44M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 355.30M |
| Shareholders Equity (Quarterly) | 372.80M |
| Debt to Equity Ratio | 0.5695 |
| Current Ratio | 2.330 |
| Net Debt Paydown Yield | -2.05% |